Pooled analysis of two studies evaluating efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis

PURPOSE: Two individual phase 3 conjunctival allergen challenge (CAC) studies of similar design have assessed the efficacy and safety of olopatadine hydrochloride (HCl) 0.77% for the treatment of allergic conjunctivitis. The purpose of this study is to evaluate the integrated efficacy and safety of...

Descripción completa

Detalles Bibliográficos
Autores principales: McLaurin, Eugene, Bergmann, Mark, Narvekar, Abhijit, Adewale, Adeniyi, Gomes, Paul, Torkildsen, Gail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472412/
https://www.ncbi.nlm.nih.gov/pubmed/28652694
http://dx.doi.org/10.2147/OPTH.S131830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472412/
https://www.ncbi.nlm.nih.gov/pubmed/28652694
http://dx.doi.org/10.2147/OPTH.S131830

Ejemplares similares